Skip to the page

Data / Medical devices / South Korea / Imani

Imani: FDA-registered device maker in Yongin Gyeonggi, South Korea, 3 510(k) clearances

Imani is registered with the FDA (registration 3018159965) in Yongin Gyeonggi, South Korea. It lists 1 device type. The FDA files 3 510(k) clearances under its listings, the newest dated March 3, 2023. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3018159965
Address
147, Hwasan-ro, Idong-eup, Cheoin-gu, Yongin-si, Gyeonggi-do, Republic of Korea., Yongin Gyeonggi, South Korea, 17135
Owner or operator
imani (10080975)
Roles
Manufacturer
First device listed
March 9, 2021
Registered through
2026
Brand names listed
imani i1, imani i1Plus, imani i2, imani i2Plus, imani i2Plus Pro

Devices it lists

DeviceProduct codeClassRoleSource
Pump, Breast, PoweredHGX2Manufactureraccessdata.fda.gov

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
March 3, 2023K222573imani i2Plus Breast PumpHGXSubstantially EquivalentImani Co.accessdata.fda.gov
March 1, 2021K202037imani i2HGXSubstantially EquivalentImani Co.accessdata.fda.gov
February 26, 2021K202045imani i1HGXSubstantially EquivalentImani Co.accessdata.fda.gov

Compare with other makers

Updated March 3, 2023. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.